StockData
Prime Medicine, Inc. logo

Prime Medicine, Inc. (PRME) stock

PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$3.55−0.29 (-7.55%)

Close on Nov 20, 2026Market cap $643.89MP/E –Yield –

Prime Medicine gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Prime Medicine

Prime Medicine has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Prime Medicine figures

See a number that looks wrong?